Notice: file_put_contents(): Write of 9152 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/251676 -
Telegram Group & Telegram Channel
亚盛医药公布2024年业绩:迈入全球创新新阶段

亚盛医药2024年实现收入9.81亿元,同比增长342%,主要得益于武田制药的选择权付款及耐立克®的强劲销售。耐立克®2024年销售收入达2.41亿元,同比增长52%。公司完成美国纳斯达克首次公开发售,募资净额9.67亿元。报告期内,lisaftoclax(APG-2575)在中国的新药上市申请获受理并纳入优先审评,公司正开展十项注册临床研究。亚盛医药在商业化、临床开发及全球合作方面取得显著进展,计划进一步加速产品管线的临床开发。

媒体报道
亚盛医药公布2024年业绩:迈入全球创新新阶段 医药魔方
收入大涨342%,亚盛医药迈入“全球创新”新阶段 格隆汇
亚盛医药:2024年核心产品耐立克销售同比增长52% 全球创新全面步入收获期 中证网

事件追踪
2024-08-23 亚盛医药:上半年收入8.24亿元,同比增长477%
2024-06-21 亚盛医药宣布已收到武田7500万美元股权投资款项
2024-02-14 亚盛医药:获美国FDA批准开展奥雷巴替尼全球注册3期试验
2019-10-28 亚盛医药正式登陆港交所,超额认购约751倍

#热门话题



tg-me.com/readhub_cn/251676
Create:
Last Update:

亚盛医药公布2024年业绩:迈入全球创新新阶段

亚盛医药2024年实现收入9.81亿元,同比增长342%,主要得益于武田制药的选择权付款及耐立克®的强劲销售。耐立克®2024年销售收入达2.41亿元,同比增长52%。公司完成美国纳斯达克首次公开发售,募资净额9.67亿元。报告期内,lisaftoclax(APG-2575)在中国的新药上市申请获受理并纳入优先审评,公司正开展十项注册临床研究。亚盛医药在商业化、临床开发及全球合作方面取得显著进展,计划进一步加速产品管线的临床开发。

媒体报道
亚盛医药公布2024年业绩:迈入全球创新新阶段 医药魔方
收入大涨342%,亚盛医药迈入“全球创新”新阶段 格隆汇
亚盛医药:2024年核心产品耐立克销售同比增长52% 全球创新全面步入收获期 中证网

事件追踪
2024-08-23 亚盛医药:上半年收入8.24亿元,同比增长477%
2024-06-21 亚盛医药宣布已收到武田7500万美元股权投资款项
2024-02-14 亚盛医药:获美国FDA批准开展奥雷巴替尼全球注册3期试验
2019-10-28 亚盛医药正式登陆港交所,超额认购约751倍

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/251676

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

The SSE was the first modern stock exchange to open in China, with trading commencing in 1990. It has now grown to become the largest stock exchange in Asia and the third-largest in the world by market capitalization, which stood at RMB 50.6 trillion (US$7.8 trillion) as of September 2021. Stocks (both A-shares and B-shares), bonds, funds, and derivatives are traded on the exchange. The SEE has two trading boards, the Main Board and the Science and Technology Innovation Board, the latter more commonly known as the STAR Market. The Main Board mainly hosts large, well-established Chinese companies and lists both A-shares and B-shares.

A project of our size needs at least a few hundred million dollars per year to keep going,” Mr. Durov wrote in his public channel on Telegram late last year. “While doing that, we will remain independent and stay true to our values, redefining how a tech company should operate.

Readhub from sg


Telegram Readhub
FROM USA